3D Bioprinting Market Size, Share & Trends Analysis Report By Technology (Magnetic Levitation, Inkjet Based, Syringe Based, Laser Based), By Application, And Segment Forecasts, 2012 - 2024

  • ID: 4538801
  • Report
  • 97 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • 3D Systems
  • Aspect Biosystems
  • BioBots
  • Cyfuse Biomedical
  • Luxexcel Group BV
  • Organovo
  • MORE
The global 3D bioprinting market is expected to reach USD 2.6 billion by 2024. Growing use of 3D printing in cosmetic surgery and drug testing coupled with increasing demand for 3D bio-printed organs is expected to drive the market growth during the forecast period.

Currently, 3D bioprinting is used for printing medical instruments, prosthetics, and dental & bone implants. However, its application is expected to grow in pharmaceutical manufacturing as it helps in reducing the overall cost of drug manufacturing.

Spritam (levetiracetam) manufactured by Aprecia Pharmaceutical, a specialty pharmaceutical company, became the first 3D bio-printed drug to gain FDA approval in March 2016. The application of 3D bioprinting in pharmaceutical manufacturing is expected to grow, thereby, contributing to the market growth during the forecast period.

Rising incidences of chronic illnesses leading to organ and tissue transplants coupled with the increasing life span of individuals and limited number of organ donors are expected to be the major drivers for the market growth. The advancement in technology and incorporation of IT within the healthcare industry, rising geriatric population base, and improving R&D efforts for the sector is also expected to propel the 3D bioprinting market over the forecast period.

Rising investment and research in 3D bioprinting is also expected to contribute to the market growth during the forecast period. The increasing R&D expenditure, availability of venture capital, and government grants are facilitating research activities in the 3D bioprinting technology. This is expected to increase the influx of advanced technologies for 3D bioprinting.

Further key findings from the report suggest:
  • The global Syringe based 3D bioprinting market is anticipated to reach 923.5 million by 2024, at a CAGR of 17.8% from 2016 to 2024
  • In terms of technology, magnetic levitation segment is expected to show the fastest growth during the forecast period
  • In terms of application, dental segment is expected to show the fastest growth over the forecast period
  • North America is expected to dominate the 3D bioprinting market during the forecast period
  • Asia pacific is predicted to show the fastest growth in 3D bioprinting market over the forecast period
  • The market is partially consolidated and competitive in nature, with presence of global multinational players
  • Some of the key companies present in the market include Organovo Holding Inc., Cyfuse Biomedical, BioBots, Luxexcel Group BV, TeVido BioDevices, Aspect Biosystems, 3Dynamics Systems, Stratasys Ltd., Voxeljet, Oceanz, Materialise NV, Envision TEC, Bio3D Technologies, Solidscape and others


PLEASE NOTE:
This report will be completed after order and will take approximately 1-2 business days after the confirmation of payment.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3D Systems
  • Aspect Biosystems
  • BioBots
  • Cyfuse Biomedical
  • Luxexcel Group BV
  • Organovo
  • MORE
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources

Chapter 2. Executive Summary
2.1. 3D Bioprinting Market - Industry Snapshot and Key Buying Criteria, 2015

Chapter 3. 3D Bioprinting Market Industry Outlook
3.1. 3D Bioprinting Market: Segmentation
3.2. 3D Bioprinting Market: Size And Growth Prospects
3.3. 3D Bioprinting Value Chain Analysis
3.4. 3D Bioprinting Market: Market Dynamics
3.4.1. Market Driver Analysis
3.4.2. Market Restraint Analysis
3.5. Key Opportunities Prioritized
3.6. Industry Analysis - Porter's
3.7. 3D Bioprinting Company Market Share, 2015
3.8. 3D Bioprinting Market: PESTEL Analysis, 2015
3.9. 3D Bioprinting Future Prospects
3.10. 3D Bioprinting Technology Overview

Chapter 4. 3D Bioprinting Market Technology Outlook
4.1. 3D Bioprinting Market Share, By Technology, 2015 & 2024
4.2. Magnetic Levitation 3D Bioprinting
4.2.1. Magnetic Levitation 3D Bioprinting Market Estimates And Forecasts, 2012 - 2024 (USD Million)
4.3. Inkjet Based 3D Bioprinting
4.3.1. Inkjet Based 3D Bioprinting Market Estimates And Forecasts, 2012 - 2024 (USD Million)
4.4. Syringe Based 3D Bioprinting
4.4.1. Syringe Based 3D Bioprinting Market Estimates And Forecasts, 2012 - 2024 (USD Million)
4.5. Laser Based 3D Bioprinting
4.5.1. Laser Based 3D Bioprinting Market Estimates And Forecasts, 2012 - 2024 (USD Million)
4.6. Others
4.6.1. Other 3D Bioprinting Market Estimates And Forecasts, 2012 - 2024 (USD Million)

Chapter 5. 3D Bioprinting Market Application Outlook
5.1. 3D Bioprinting Market Share, By Application, 2015 & 2024
5.2. Medical
5.2.1. 3D Bioprinting Medical Market Estimates And Forecasts, 2012 - 2024 (USD Million)
5.2.2. Tissue And Organ Generation
5.2.2.1. Tissue And Organ Generation Market Estimates and Forecasts, 2012 - 2024 (USD Million)
5.2.3. Medical Pills
5.2.3.1. Medical Pills Market Estimates and Forecasts, 2012 - 2024 (USD Million)
5.2.4. Prosthetics And Implants
5.2.4.1. Prosthetics And Implants Market Estimates and Forecasts, 2012 - 2024 (USD Million)
5.3. Dental
5.3.1. 3D Bioprinting Dental Market Estimates And Forecasts, 2012 - 2024 (USD Million)
5.4. Biosensors
5.4.1. 3D Bioprinting Biosensors Market Estimates And Forecasts, 2012 - 2024 (USD Million)
5.5. Consumer/Personal Product Testing
5.5.1. 3D Bioprinting Consumer/ Personal Product Testing Market Estimates And Forecasts, 2012 - 2024 (USD Million)
5.6. Bioinks
5.6.1. 3D Bioprinting Bioinks Market Estimates And Forecasts, 2012 - 2024 (USD Million)
5.7. Food And Animal Product
5.7.1. 3D Bioprinting Food And Animal Product Market Estimates And Forecasts, 2012 - 2024 (USD Million)

Chapter 6. 3D Bioprinting Market Regional Outlook
6.1. 3D Bioprinting Market Share, By Region, 2015 & 2024
6.2. North America
6.2.1. North America 3D Bioprinting Market Estimates And Forecasts, By Technology, 2012 - 2024 (USD Million)
6.2.2. North America 3D Bioprinting Market Estimates And Forecasts, By Application, 2012 - 2024 (USD Million)
6.3. Europe
6.3.1. Europe 3D Bioprinting Market Estimates And Forecasts, By Technology, 2012 - 2024 (USD Million)
6.3.2. Europe 3D Bioprinting Market Estimates And Forecasts, By Application, 2012 - 2024 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific 3D Bioprinting Market Estimates And Forecasts, By Technology, 2012 - 2024 (USD Million)
6.4.2. Asia Pacific 3D Bioprinting Market Estimates And Forecasts, By Application, 2012 - 2024 (USD Million)
6.5. Latin America
6.5.1. Latin America 3D Bioprinting Market Estimates And Forecasts, By Technology, 2012 - 2024 (USD Million)
6.5.2. Latin America 3D Bioprinting Market Estimates And Forecasts, By Application, 2012 - 2024 (USD Million)
6.6. MEA
6.6.1. MEA 3D Bioprinting Market Estimates And Forecasts, By Technology, 2012 - 2024 (USD Million)
6.6.2. MEA 3D Bioprinting Market Estimates And Forecasts, By Application, 2012 - 2024 (USD Million)

Chapter 7. Competitive Landscape
7.1. 3D Systems
7.1.1. Company Overview
7.1.2. Financial Performance
7.1.3. Product Benchmarking
7.1.4. Strategic Initiatives
7.2. Organovo
7.2.1. Company Overview
7.2.2. Financial Performance
7.2.3. Product Benchmarking
7.2.4. Strategic Initiatives
7.3. CELLINK
7.3.1. Company Overview
7.3.2. Financial Performance
7.3.3. Product Benchmarking
7.3.4. Strategic Initiatives
7.4. Envision TEC
7.4.1. Company Overview
7.4.2. Financial Performance
7.4.3. Product Benchmarking
7.4.4. Strategic Initiatives
7.5. Materialise NV
7.5.1. Company Overview
7.5.2. Financial Performance
7.5.3. Product Benchmarking
7.5.4. Strategic Initiatives
7.6. Bio3D Technologies
7.6.1. Company Overview
7.6.2. Financial Performance
7.6.3. Product Benchmarking
7.6.4. Strategic Initiatives
7.7. Oceanz 3D printing & Additive Manufacturing
7.7.1. Company Overview
7.7.2. Financial Performance
7.7.3. Product Benchmarking
7.7.4. Strategic Initiatives
7.8. Solidscape
7.8.1. Company Overview
7.8.2. Financial Performance
7.8.3. Product Benchmarking
7.8.4. Strategic Initiatives
7.9. Stratasys Ltd.
7.9.1. Company Overview
7.9.2. Financial Performance
7.9.3. Product Benchmarking
7.9.4. Strategic Initiatives
7.10. Voxeljet
7.10.1. Company Overview
7.10.2. Financial Performance
7.10.3. Product Benchmarking
7.10.4. Strategic Initiatives
7.11. Luxexcel Group BV
7.11.1. Company Overview
7.11.2. Financial Performance
7.11.3. Product Benchmarking
7.11.4. Strategic Initiatives
7.12. TeVido BioDevices
7.12.1. Company Overview
7.12.2. Financial Performance
7.12.3. Product Benchmarking
7.12.4. Strategic Initiatives
7.13. 3Dynamics Systems
7.13.1. Company Overview
7.13.2. Financial Performance
7.13.3. Product Benchmarking
7.13.4. Strategic Initiatives
7.14. Aspect Biosystems
7.14.1. Company Overview
7.14.2. Financial Performance
7.14.3. Product Benchmarking
7.14.4. Strategic Initiatives
7.15. BioBots
7.15.1. Company Overview
7.15.2. Financial Performance
7.15.3. Product Benchmarking
7.15.4. Strategic Initiatives
7.16. Cyfuse Biomedical
7.16.1. Company Overview
7.16.2. Financial Performance
7.16.3. Product Benchmarking
7.16.4. Strategic Initiatives

List of Tables

Table 1 3D bioprinting - Industry Snapshot & Key Buying Criteria, 2012 - 2024
Table 2 3D bioprinting market, by technology, 2012 - 2024 (USD Million)
Table 3 3D bioprinting market, by application, 2012 - 2024 (USD Million)
Table 4 3D bioprinting medical market, by application, 2012 - 2024 (USD Million)
Table 5 3D bioprinting market, by region, 2012 - 2024 (USD Million)
Table 6 3D bioprinting - Key market driver analysis
Table 7 3D bioprinting - Key market restraint analysis
Table 8 North America 3D bioprinting market, by region, 2012 - 2024 (USD Million)
Table 9 North America 3D bioprinting market, by technology 2012 - 2024 (USD Million)
Table 10 North America 3D bioprinting market, by application, 2012 - 2024 (USD Million)
Table 11 North America 3D bioprinting medical market, by technology, 2012 - 2024 (USD Million)
Table 12 U.S. 3D bioprinting market, by technology 2012 - 2024 (USD Million)
Table 13 U.S. 3D bioprinting market, by application, 2012 - 2024 (USD Million)
Table 14 U.S. 3D bioprinting medical market, by application, 2012 - 2024 (USD Million)
Table 15 Canada 3D bioprinting market, by technology 2012 - 2024 (USD Million)
Table 16 Canada 3D bioprinting market, by application, 2012 - 2024 (USD Million)
Table 17 Canada 3D bioprinting medical market, by application, 2012 - 2024 (USD Million)
Table 18 Europe 3D bioprinting market, by region, 2012 - 2024 (USD Million)
Table 19 Europe 3D bioprinting market, by technology 2012 - 2024 (USD Million)
Table 20 Europe 3D bioprinting market, by application, 2012 - 2024 (USD Million)
Table 21 Europe 3D bioprinting medical market, by application, 2012 - 2024 (USD Million)
Table 22 Germany 3D bioprinting market, by technology 2012 - 2024 (USD Million)
Table 23 Germany 3D bioprinting market, by application, 2012 - 2024 (USD Million)
Table 24 Germany 3D bioprinting medical market, by application, 2012 - 2024 (USD Million)
Table 25 UK 3D bioprinting market, by technology 2012 - 2024 (USD Million)
Table 26 UK 3D bioprinting market, by application, 2012 - 2024 (USD Million)
Table 27 UK 3D bioprinting medical market, by application, 2012 - 2024 (USD Million)
Table 28 Asia Pacific 3D bioprinting market, by region, 2012 - 2024 (USD Million)
Table 29 Asia Pacific 3D bioprinting market, by technology 2012 - 2024 (USD Million)
Table 30 Asia Pacific 3D bioprinting market, by application, 2012 - 2024 (USD Million)
Table 31 Asia Pacific 3D bioprinting medical market, by application, 2012 - 2024 (USD Million)
Table 32 China 3D bioprinting market, by technology 2012 - 2024 (USD Million)
Table 33 China 3D bioprinting market, by application, 2012 - 2024 (USD Million)
Table 34 China 3D bioprinting medical market, by application, 2012 - 2024 (USD Million)
Table 35 Japan 3D bioprinting market, by technology 2012 - 2024 (USD Million)
Table 36 Japan 3D bioprinting market, by application, 2012 - 2024 (USD Million)
Table 37 Japan 3D bioprinting medical market, by application, 2012 - 2024 (USD Million)
Table 38 Latin America 3D bioprinting market, by region, 2012 - 2024 (USD Million)
Table 39 Latin America 3D bioprinting market, by technology 2012 - 2024 (USD Million)
Table 40 Latin America 3D bioprinting market, by application, 2012 - 2024 (USD Million)
Table 41 Latin America 3D bioprinting medical market, by application, 2012 - 2024 (USD Million)
Table 42 Brazil 3D bioprinting market, by technology 2012 - 2024 (USD Million)
Table 43 Brazil 3D bioprinting market, by application, 2012 - 2024 (USD Million)
Table 44 Brazil 3D bioprinting medical market, by application, 2012 - 2024 (USD Million)
Table 45 MEA 3D bioprinting market, by region, 2012 - 2024 (USD Million)
Table 46 MEA 3D bioprinting market, by technology 2012 - 2024 (USD Million)
Table 47 MEA 3D bioprinting market, by application, 2012 - 2024 (USD Million)
Table 48 MEA 3D bioprinting medical market, by application, 2012 - 2024 (USD Million)
Table 49 South Africa 3D bioprinting market, by technology 2012 - 2024 (USD Million)
Table 50 South Africa 3D bioprinting market, by application, 2012 - 2024 (USD Million)
Table 51 South Africa 3D bioprinting medical market, by application, 2012 - 2024 (USD Million)

List of Figures

FIG. 1 Global 3D bioprinting: Market segmentation
FIG. 2 3D bioprinting market, 2012 - 2024 (USD Million)
FIG. 3 3D bioprinting: Market dynamics
FIG. 4 Key opportunities prioritized
FIG. 5 3D bioprinting for core conditions
FIG. 6 3D bioprinting for secondary conditions
FIG. 7 3D bioprinting market - Porter’s analysis
FIG. 8 3D bioprinting company market share, 2015
FIG. 9 3D bioprinting market - PESTEL analysis
FIG. 10 3D bioprinting revenue share by technology, 2015 & 2024
FIG. 11 Magnetic levitation 3D bioprinting market, 2012 - 2024 (USD Million)
FIG. 12 Inkjet based 3D bioprinting market, 2012 - 2024 (USD Million)
FIG. 13 Syringe based 3D bioprinting market, 2012 - 2024 (USD Million)
FIG. 14 Laser based 3D bioprinting market, 2012 - 2024 (USD Million)
FIG. 15 Others 3D bioprinting market, 2012 - 2024 (USD Million)
FIG. 17 3D bioprinting revenue share by application, 2014 & 2022
FIG. 18 Medical 3D bioprinting market, 2012 - 2024 (USD Million)
FIG. 19 Tissue and organ generation 3D bioprinting medical market, 2012 - 2024 (USD Million)
FIG. 20 Medical pills based 3D bioprinting medical market, 2012 - 2024 (USD Million)
FIG. 21 Prosthetics and implants based 3D bioprinting medical market, 2012 - 2024 (USD Million)
FIG. 22 Dental 3D bioprinting market, 2012 - 2024 (USD Million)
FIG. 23 Biosensors 3D bioprinting market, 2012 - 2024 (USD Million)
FIG. 24 Consumer/Personal product testing 3D bioprinting market, 2012 - 2024 (USD Million)
FIG. 25 Dental 3D bioprinting market, 2012 - 2024 (USD Million)
FIG. 26 Bioinks 3D bioprinting market, 2012 - 2024 (USD Million)
FIG. 27 Food and animal product 3D bioprinting market, 2012 - 2024 (USD Million)
FIG. 28 3D bioprinting market share, by region, 2014 & 2022
FIG. 29 North America 3D bioprinting market, 2012 - 2024 (USD Million)
FIG. 30 U.S. 3D bioprinting market, 2012 - 2024 (USD Million)
FIG. 31 Canada 3D bioprinting market, 2012 - 2024 (USD Million)
FIG. 32 Europe 3D bioprinting market, 2012 - 2024 (USD Million)
FIG. 33 Germany 3D bioprinting market, 2012 - 2024 (USD Million)
FIG. 34 UK 3D bioprinting market, 2012 - 2024 (USD Million)
FIG. 35 Asia Pacific 3D bioprinting market, 2012 - 2024 (USD Million)
FIG. 36 China 3D bioprinting market, 2012 - 2024 (USD Million)
FIG. 37 Japan 3D bioprinting market, 2012 - 2024 (USD Million)
FIG. 38 Latin America 3D bioprinting market, 2012 - 2024 (USD Million)
FIG. 39 Brazil 3D bioprinting market, 2012 - 2024 (USD Million)
FIG. 40 MEA 3D bioprinting market, 2012 - 2024 (USD Million)
FIG. 41 South Africa 3D bioprinting market, 2012 - 2024 (USD Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 3D Systems
  • Organovo
  • CELLINK
  • Envision TEC
  • Materialise NV
  • Bio3D Technologies
  • Oceanz 3D printing & Additive Manufacturing
  • Solidscape
  • Stratasys Ltd.
  • Voxeljet
  • Luxexcel Group BV
  • TeVido BioDevices
  • 3Dynamics Systems
  • Aspect Biosystems
  • BioBots
  • Cyfuse Biomedical
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll